Literature DB >> 11760159

Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico.

D B Huang1, Z D Jiang, C D Ericsson, J Adachi, H L Dupont.   

Abstract

Thirty-nine healthy US students without diarrheal disease and who had not received prophylactic or therapeutic antibiotics were monitored for emergence of trimethoprim-resistant gram-negative fecal flora for a 3-week period after arrival in Guadalajara, Mexico. During this time period, most students showed no change in total fecal gram-negative bacteria (p > 0.05) but showed an increasing level of trimethoprim (TMP) resistance (p < 0.01) among fecal coliforms. Escherichia coli was the TMP-resistant organism isolated in 18 of 39 (46%) healthy students. These 18 TMP-resistant E. coli were also resistant to ampicillin (44%), azithromycin (11%), chloramphenicol (39%), ciprofloxacin (11%), doxycycline (89%), erythromycin (100%), furazolidone (72%), levofloxacin (17%), trimethoprim-sulfamethoxazole (89%) and trovafloxacin (17%). In the absence of prophylactic and therapeutic antibiotics, increased acquisition of TMP-resistant gram-negative fecal flora in this developing country is probably due to poor sanitary conditions and the recurrent and heavy exposure to antimicrobial-resistant indigenous flora as a result of contaminated food and drink.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11760159     DOI: 10.1080/00365540110076589

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  High prevalence of MDR gram-negative bacteria in feces of healthy blood donors in Mexico.

Authors:  Karla M Tamez-Torres; Alfredo Ponce-de-Leon; Pedro Torres-Gonzalez; Esteban Perez-Garcia; Estefania Torres-Veintimilla; Miriam Bobadilla-Del Valle; Jose Sifuentes-Osornio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-03-13       Impact factor: 3.267

2.  Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli.

Authors:  Matthew H Samore; Claude Tonnerre; Elizabeth Lyon Hannah; Gregory J Stoddard; Robert J Borotkanics; Bassam Haddadin; Stephan Harbarth
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 3.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.